<prompt> Answer this question truthfullyWhich antitumor monoclonal antibody is associated with the risk of developing progressive multifocal leukoencephalopathy PML?  <response>: <reason> Rituximab is the antitumor monoclonal antibody that is associated with the risk of developing progressive multifocal leukoencephalopathy PML. 